http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S58222077-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ef6ef5fcea57c992721adbad835fdfa
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08
filingDate 1982-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_404adc2a624f24a13104042494352f17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_280d0d71011dfcc7220acd1476c124d4
publicationDate 1983-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S58222077-A
titleOfInvention Preparation of 1-(4-hydroxyphenyl)-2-(4-benzyl- piperidino)-propan-1-ol tartaric acid salt
abstract PURPOSE: To prepare the titled substance useful as a drug, in high efficiency, by using the novel α-(4-benzylpiperidino)-propionaldehyde as a starting material, reacting the material with 4-benzyloxyphenyl-magnesium halide, and then reacting with hydrogen in the presence of tartaric acid and a catalyst. n CONSTITUTION: The objective compound is prepared by reacting α-(4-benzyl- piperidino)-propionaldehyde with 4-benzyloxyphenylmagnesium halide to obtain 1- (4-benzyloxyphenyl)-2-(4-benzylpiperidino)-propan-1-ol, and reacting the product with hydrogen in the presence of tartaric acid and a reducing catalyst. The novel compound used as the starting material can be synthesized by reacting α- bromopropion-aldehyde acetal with 4-benzylpiperidine, and hydrolyzing the resultant α-(4-benzylpiperidino)-propionaldehyde acetal under acidic condition. n COPYRIGHT: (C)1983,JPO&Japio
priorityDate 1982-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226465753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448732235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426398245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6419987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226696573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9823148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88729910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236352196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236352202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426634869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234411697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236353033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13276624
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70523027

Total number of triples: 33.